81 FR 1191 - Board of Scientific Counselors, National Center for Injury Prevention and Control, (BSC, NCIPC)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 81, Issue 6 (January 11, 2016)

[Federal Register Volume 81, Number 6 (Monday, January 11, 2016)]
[Notices]
[Pages 1191-1192]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-00265]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, National Center for Injury 
Prevention and Control, (BSC, NCIPC)

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces, the following meeting of the aforementioned 
committee:
    Time and Date: 9:00 a.m.-3:00 p.m., EST, January 28, 2016 (OPEN).
    Public Comment Time and Date: 1:00 p.m.-2:30 p.m.*, EST, January 
28, 2016.
    * Please note that the public comment period ends at the time 
indicated above or following the last call for comments, whichever is 
earlier. Members of the public who want to submit comments must pre-
register by January 18, 2016 to [email protected]. All requests 
must contain the name, address, email address, organizational 
affiliation of the speaker, and the topic being addressed with 
accompanying written comments. Written comments should be limited to 
one page single spaced with 1 inch margins.
    Members of the public must indicate at pre-registration whether 
they would like to deliver oral remarks in addition to written comment. 
Comments may be delivered in person or by phone and will be assigned on 
a first come-first served basis until all time slots are filled. 
Speakers providing public comment must call in or be present at the 
beginning of the public comment period. All public comments will be 
limited to two minutes per speaker. Since the number of time slots is 
limited, it is requested that each organization register one speaker to 
represent their organization. Both oral and written comments will be 
included in the official record of the meeting.
    Place: Centers for Disease Control and Prevention, Building 21, 
Auditorium B-3, 1600 Clifton Road NE., Atlanta, GA 30329.
    Audio Conference toll-free dial-in Number: 1-888-469-1243, 
Participant Code: 4709506, TTY accessible link: http://www.captionedtext.com/client/event.aspx?CustomerID=1891&EventID=2812716.
    CDC encourages participation by persons with disabilities. Captions 
and participation by persons with communications challenges will be 
available online via Relay Conference Captioning. To view the online 
captions at the start time of the event, please login for captioning at 
http://www.captionedtext.com/client/event.aspx?CustomerID=1891&EventID=2812716.
    Requests for accommodations, questions, or comments on 
accessibility (Section 508) compliance may be directed to Tonia 
Lindley, [email protected].
    Status: The meeting as designated above will be open to the public 
limited only by the space available. The meeting room will accommodate 
up to 200 people. See instructions above regarding pre-registration and 
delivering public comment.
    Purpose: The Board will: (1) Conduct, encourage, cooperate with, 
and assist other appropriate public health authorities, scientific 
institutions, and scientists in the conduct of research, 
investigations, experiments, demonstrations, and studies relating to 
the causes, diagnosis, treatment, control, and prevention of physical 
and mental diseases, and other impairments; (2) assist States and their 
political subdivisions in preventing and suppressing communicable and 
non-communicable diseases and other preventable conditions and in 
promoting health and well-being; and (3) conduct and assist in research 
and control activities related to injury.
    The Board of Scientific Counselors makes recommendations regarding 
policies, strategies, objectives, and priorities; and reviews progress 
toward injury prevention goals and provides

[[Page 1192]]

evidence in injury prevention-related research and programs. The Board 
also provides advice on the appropriate balance of intramural and 
extramural research, the structure, progress and performance of 
intramural programs. The Board is designed to provide guidance on 
extramural scientific program matters, including the: (1) Review of 
extramural research concepts for funding opportunity announcements; (2) 
conduct of Secondary Peer Review of extramural research grants, 
cooperative agreements, and contracts applications received in response 
to the funding opportunity announcements as it relates to the Center's 
programmatic balance and mission; (3) submission of secondary review 
recommendations to the Center Director of applications to be considered 
for funding support; (4) review of research portfolios, and (5) review 
of program proposals.
    Matters for Discussion: The Board of Scientific Counselors will 
discuss the draft recommendations in the CDC Guideline for Prescribing 
Opioids for Chronic Pain (Guideline), as well as observations 
formulated in the Opioid Guideline Workgroup Report. There will be 90 
minutes allotted for public comments at the end of the session. See 
above instructions on pre-registration for public comment. A transcript 
of the meeting and public comments received at the meeting will be 
posted to the docket at www.regulations.gov (Docket No. CDC-2015-0112).
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Arlene Greenspan, Dr.P.H., 
M.P.H., P.T. Associate Director for Science, NCIPC, CDC, 4770 Buford 
Highway NE., Mailstop F-63, Atlanta, GA 30341, Telephone (770) 488-
4696; Email [email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2016-00265 Filed 1-8-16; 8:45 am]
BILLING CODE 4163-18-P